BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 25761664)

  • 21. Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch(®) CTC test.
    Adams DL; Stefansson S; Haudenschild C; Martin SS; Charpentier M; Chumsri S; Cristofanilli M; Tang CM; Alpaugh RK
    Cytometry A; 2015 Feb; 87(2):137-44. PubMed ID: 25515318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid isolation of viable circulating tumor cells from patient blood samples.
    Hughes AD; Mattison J; Powderly JD; Greene BT; King MR
    J Vis Exp; 2012 Jun; (64):e4248. PubMed ID: 22733259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating Tumor Cells: A Review of Non-EpCAM-Based Approaches for Cell Enrichment and Isolation.
    Gabriel MT; Calleja LR; Chalopin A; Ory B; Heymann D
    Clin Chem; 2016 Apr; 62(4):571-81. PubMed ID: 26896446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved detection by ensemble-decision aliquot ranking of circulating tumor cells with low numbers of a targeted surface antigen.
    Johnson ES; Anand RK; Chiu DT
    Anal Chem; 2015 Sep; 87(18):9389-95. PubMed ID: 26302174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of novel markers that outperform EpCAM in quantifying circulating tumor cells.
    Kim MJ; Choi NY; Lee EK; Kang MS
    Cell Oncol (Dordr); 2014 Aug; 37(4):235-43. PubMed ID: 25001871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterogeneous detection of circulating tumor cells in patients with colorectal cancer by immunomagnetic enrichment using different EpCAM-specific antibodies.
    Antolovic D; Galindo L; Carstens A; Rahbari N; Büchler MW; Weitz J; Koch M
    BMC Biotechnol; 2010 Apr; 10():35. PubMed ID: 20426872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating Tumor Cells Enriched by the Depletion of Leukocytes with Bi-Antibodies in Non-Small Cell Lung Cancer: Potential Clinical Application.
    Yin J; Wang Y; Yin H; Chen W; Jin G; Ma H; Dai J; Chen J; Jiang Y; Wang H; Liu Z; Hu Z; Shen H
    PLoS One; 2015; 10(8):e0137076. PubMed ID: 26317979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microfluidic immunodetection of cancer cells via site-specific microcontact printing of antibodies on nanoporous surface.
    Ng E; Hoshino K; Zhang X
    Methods; 2013 Oct; 63(3):266-75. PubMed ID: 24012763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A combined micromagnetic-microfluidic device for rapid capture and culture of rare circulating tumor cells.
    Kang JH; Krause S; Tobin H; Mammoto A; Kanapathipillai M; Ingber DE
    Lab Chip; 2012 Jun; 12(12):2175-81. PubMed ID: 22453808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual-Multivalent-Aptamer-Conjugated Nanoprobes for Superefficient Discerning of Single Circulating Tumor Cells in a Microfluidic Chip with Inductively Coupled Plasma Mass Spectrometry Detection.
    Zhang X; Wei X; Men X; Wu CX; Bai JJ; Li WT; Yang T; Chen ML; Wang JH
    ACS Appl Mater Interfaces; 2021 Sep; 13(36):43668-43675. PubMed ID: 34473482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved Circulating Tumor Cell Detection by a Combined EpCAM and MCAM CellSearch Enrichment Approach in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy.
    Onstenk W; Kraan J; Mostert B; Timmermans MM; Charehbili A; Smit VT; Kroep JR; Nortier JW; van de Ven S; Heijns JB; Kessels LW; van Laarhoven HW; Bos MM; van de Velde CJ; Gratama JW; Sieuwerts AM; Martens JW; Foekens JA; Sleijfer S
    Mol Cancer Ther; 2015 Mar; 14(3):821-7. PubMed ID: 25552367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research.
    Grover PK; Cummins AG; Price TJ; Roberts-Thomson IC; Hardingham JE
    Ann Oncol; 2014 Aug; 25(8):1506-16. PubMed ID: 24651410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ex vivo and in vivo capture and deactivation of circulating tumor cells by dual-antibody-coated nanomaterials.
    Xie J; Gao Y; Zhao R; Sinko PJ; Gu S; Wang J; Li Y; Lu Y; Yu S; Wang L; Chen S; Shao J; Jia L
    J Control Release; 2015 Jul; 209():159-69. PubMed ID: 25933713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The architecture and biological function of dual antibody-coated dendrimers: enhanced control of circulating tumor cells and their hetero-adhesion to endothelial cells for metastasis prevention.
    Xie J; Zhao R; Gu S; Dong H; Wang J; Lu Y; Sinko PJ; Yu T; Xie F; Wang L; Shao J; Jia L
    Theranostics; 2014; 4(12):1250-63. PubMed ID: 25285173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycomechanics of the metastatic cascade: tumor cell-endothelial cell interactions in the circulation.
    Geng Y; Marshall JR; King MR
    Ann Biomed Eng; 2012 Apr; 40(4):790-805. PubMed ID: 22101756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surface engineering for efficient capture of circulating tumor cells in renal cell carcinoma: From nanoscale analysis to clinical application.
    Bu J; Nair A; Kubiatowicz LJ; Poellmann MJ; Jeong WJ; Reyes-Martinez M; Armstrong AJ; George DJ; Wang AZ; Zhang T; Hong S
    Biosens Bioelectron; 2020 Aug; 162():112250. PubMed ID: 32392161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating tumor cells: clinically relevant molecular access based on a novel CTC flow cell.
    Winer-Jones JP; Vahidi B; Arquilevich N; Fang C; Ferguson S; Harkins D; Hill C; Klem E; Pagano PC; Peasley C; Romero J; Shartle R; Vasko RC; Strauss WM; Dempsey PW
    PLoS One; 2014; 9(1):e86717. PubMed ID: 24489774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual-Aptamer-Targeted Immunomagnetic Nanoparticles to Accurately Explore the Correlations between Circulating Tumor Cells and Gastric Cancer.
    Li C; Yang S; Li R; Gong S; Huang M; Sun Y; Xiong G; Wu D; Ji M; Chen Y; Gao C; Yu Y
    ACS Appl Mater Interfaces; 2022 Feb; 14(6):7646-7658. PubMed ID: 35104098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The detection of EpCAM(+) and EpCAM(-) circulating tumor cells.
    de Wit S; van Dalum G; Lenferink AT; Tibbe AG; Hiltermann TJ; Groen HJ; van Rijn CJ; Terstappen LW
    Sci Rep; 2015 Jul; 5():12270. PubMed ID: 26184843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating tumor cell enumeration with a combination of epithelial cell adhesion molecule- and cell-surface vimentin-based methods for monitoring breast cancer therapeutic response.
    Satelli A; Brownlee Z; Mitra A; Meng QH; Li S
    Clin Chem; 2015 Jan; 61(1):259-66. PubMed ID: 25336717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.